CH660009A5 - Procedimento per preparare azino rifamicine. - Google Patents
Procedimento per preparare azino rifamicine. Download PDFInfo
- Publication number
- CH660009A5 CH660009A5 CH1395/84A CH139584A CH660009A5 CH 660009 A5 CH660009 A5 CH 660009A5 CH 1395/84 A CH1395/84 A CH 1395/84A CH 139584 A CH139584 A CH 139584A CH 660009 A5 CH660009 A5 CH 660009A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- carbon atoms
- formula
- alkyl
- ring
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 10
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- BTVYFIMKUHNOBZ-ZDHWWVNNSA-N Rifamycin S Natural products COC1C=COC2(C)Oc3c(C)c(O)c4C(=O)C(=CC(=O)c4c3C2=O)NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C BTVYFIMKUHNOBZ-ZDHWWVNNSA-N 0.000 claims description 6
- BTVYFIMKUHNOBZ-ODRIEIDWSA-N Rifamycin S Chemical compound O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-ODRIEIDWSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 229930189077 Rifamycin Natural products 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 claims description 5
- 229940081192 rifamycins Drugs 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000002262 Schiff base Substances 0.000 claims description 4
- 150000004753 Schiff bases Chemical class 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 229940109171 rifamycin sv Drugs 0.000 claims description 4
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 150000003973 alkyl amines Chemical class 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229940043265 methyl isobutyl ketone Drugs 0.000 claims description 3
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical group CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 2
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 claims description 2
- -1 1,2,3,4-tetrahydro-isochinolinyl group Chemical group 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 125000005936 piperidyl group Chemical group 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- BBNQHOMJRFAQBN-UPZFVJMDSA-N 3-formylrifamycin sv Chemical compound OC1=C(C(O)=C2C)C3=C(O)C(C=O)=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BBNQHOMJRFAQBN-UPZFVJMDSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- DXVYLFHTJZWTRF-UHFFFAOYSA-N Ethyl isobutyl ketone Chemical compound CCC(=O)CC(C)C DXVYLFHTJZWTRF-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- PTXLQQZNRSWESR-UHFFFAOYSA-N 1,3,5-tritert-butyltriazinane Chemical compound CC(C)(C)C1CN(C(C)(C)C)NN(C(C)(C)C)C1 PTXLQQZNRSWESR-UHFFFAOYSA-N 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- RSUCYDXEFFBUSN-UHFFFAOYSA-N n-tert-butylmethanimine Chemical compound CC(C)(C)N=C RSUCYDXEFFBUSN-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838308166A GB8308166D0 (en) | 1983-03-24 | 1983-03-24 | Preparation of azinomethyl-rifamycins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH660009A5 true CH660009A5 (it) | 1987-03-13 |
Family
ID=10540154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1395/84A CH660009A5 (it) | 1983-03-24 | 1984-03-20 | Procedimento per preparare azino rifamicine. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4507295A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS59176291A (cg-RX-API-DMAC10.html) |
| AT (1) | AT384024B (cg-RX-API-DMAC10.html) |
| AU (1) | AU557393B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE899211A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1204740A (cg-RX-API-DMAC10.html) |
| CH (1) | CH660009A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE3410102A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK157874C (cg-RX-API-DMAC10.html) |
| FI (1) | FI78104C (cg-RX-API-DMAC10.html) |
| FR (1) | FR2543141B1 (cg-RX-API-DMAC10.html) |
| GB (2) | GB8308166D0 (cg-RX-API-DMAC10.html) |
| GR (1) | GR81481B (cg-RX-API-DMAC10.html) |
| HU (1) | HU189073B (cg-RX-API-DMAC10.html) |
| IL (1) | IL71273A (cg-RX-API-DMAC10.html) |
| IT (1) | IT1206141B (cg-RX-API-DMAC10.html) |
| NL (1) | NL8400935A (cg-RX-API-DMAC10.html) |
| SE (1) | SE456586B (cg-RX-API-DMAC10.html) |
| SU (1) | SU1486065A3 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA842135B (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8408924D0 (en) * | 1984-04-06 | 1984-05-16 | Dobfar Spa | 3-azinomethyl rifamycins |
| JPH02501301A (ja) * | 1987-09-25 | 1990-05-10 | チバ‐ガイギー アクチェンゲゼルシャフト | ４‐（トリアルキルベンジル）‐ピペラジニル化合物のジアシル誘導体 |
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR208F (cg-RX-API-DMAC10.html) * | 1964-07-31 | |||
| DE1795568C3 (de) * | 1964-07-31 | 1974-07-18 | Gruppo Lepetit S.P.A., Mailand (Italien) | 3-Hydroxymethyl-rifamycin SV und Verfahren zu seiner Herstellung. Ausscheidung aus: 1595883 |
| US3542762A (en) * | 1967-06-07 | 1970-11-24 | Lepetit Spa | Process for rifamycins |
| AR207762A1 (es) * | 1973-07-25 | 1976-10-29 | Archifar Ind Chim Trentino | Procedimiento para la preparacion de 3-((4-metil-1-piperazin-1-il)-imino)-metil-rifamicina sv o rifampicina |
| GB1594134A (en) * | 1977-11-25 | 1981-07-30 | Holco Investment Inc | Rifamycins |
| BE886395A (fr) * | 1980-02-13 | 1981-03-16 | Erba Farmitalia | Derives de rifamycine |
| IT1135270B (it) * | 1980-04-12 | 1986-08-20 | Erba Farmitalia | 3-amidino-ansamicine |
| US4447432A (en) * | 1981-11-17 | 1984-05-08 | Farmitalia Carlo Erba S.P.A. | Azino rifamycins |
| DE3239751A1 (de) * | 1982-10-27 | 1984-05-03 | Farmitalia Carlo Erba S.p.A., Mailand / Milano | Verfahren zur herstellen von azino-rifamycin-verbindungen |
| BE895041A (fr) * | 1982-11-17 | 1983-05-17 | Erba Farmitalia | Procede de preparation de composes d'azino-rifamycines |
-
1983
- 1983-03-24 GB GB838308166A patent/GB8308166D0/en active Pending
-
1984
- 1984-02-29 DK DK133784A patent/DK157874C/da not_active IP Right Cessation
- 1984-03-16 FI FI841078A patent/FI78104C/fi not_active IP Right Cessation
- 1984-03-16 AT AT0089884A patent/AT384024B/de not_active IP Right Cessation
- 1984-03-16 CA CA000449790A patent/CA1204740A/en not_active Expired
- 1984-03-19 US US06/590,649 patent/US4507295A/en not_active Expired - Fee Related
- 1984-03-19 IL IL71273A patent/IL71273A/xx unknown
- 1984-03-19 GB GB08407084A patent/GB2139619B/en not_active Expired
- 1984-03-19 JP JP59051286A patent/JPS59176291A/ja active Granted
- 1984-03-19 GR GR74151A patent/GR81481B/el unknown
- 1984-03-19 AU AU25850/84A patent/AU557393B2/en not_active Ceased
- 1984-03-20 CH CH1395/84A patent/CH660009A5/it not_active IP Right Cessation
- 1984-03-20 DE DE19843410102 patent/DE3410102A1/de active Granted
- 1984-03-20 FR FR8404259A patent/FR2543141B1/fr not_active Expired
- 1984-03-21 BE BE0/212602A patent/BE899211A/fr not_active IP Right Cessation
- 1984-03-22 IT IT8420191A patent/IT1206141B/it active
- 1984-03-22 SE SE8401609A patent/SE456586B/sv not_active IP Right Cessation
- 1984-03-22 ZA ZA842135A patent/ZA842135B/xx unknown
- 1984-03-22 SU SU843717072A patent/SU1486065A3/ru active
- 1984-03-23 NL NL8400935A patent/NL8400935A/nl not_active Application Discontinuation
- 1984-03-23 HU HU841167A patent/HU189073B/hu not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100400941B1 (ko) | 축합6환화합물및그의제조방법 | |
| AU2020219797B2 (en) | Process for preparing enantiomerically enriched jak inhibitors | |
| CN108925135B (zh) | 制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法 | |
| CN118871436A (zh) | 可用作抗癌剂的吡唑基衍生物的合成方法 | |
| TW201605814A (zh) | 用於合成經保護之ｎ－烷基三唑甲醛的三唑中間體 | |
| RS59806B1 (sr) | Postupci za pripremu citotoksičnih benzodiazepinskih derivata | |
| IL111273A (en) | Carbamoyl esters of 6-demethyl galanthamine and pharmaceutical compositions containing them | |
| AU2014219754B2 (en) | Method for producing tricyclic compound, and tricyclic compound capable of being produced by said production method | |
| JP2020534317A (ja) | チエノジアゼピン誘導体とその応用 | |
| CH660009A5 (it) | Procedimento per preparare azino rifamicine. | |
| US3825571A (en) | Mycophenolic acid derivatives | |
| CN110684048A (zh) | 一种新型磷酸肌醇3-激酶抑制剂及其制备方法和用途 | |
| JPH0327534B2 (cg-RX-API-DMAC10.html) | ||
| SE520665C2 (sv) | Diklavulanatsalt med en diaminoeter och process av preparation | |
| CN111527069B (zh) | 一类喹啉衍生物 | |
| SU1047391A3 (ru) | Способ получени производных рифамицина | |
| DE3767446D1 (de) | Einstufiges verfahren zur herstellung von gemischt substituierten 1,2-di-acyl-sn-glycero-3-phosphocholinen. | |
| CN115557967B (zh) | 4-硝基邻苯二甲酰氮杂冠醚类化合物及制备方法和应用 | |
| WO2025149076A1 (en) | Phenolic derivatives as covalent warhead targeting sulfenic acid form of cysteine | |
| SU1087518A1 (ru) | Способ получени @ , @ -метилен-бис-( @ -винилсульфонилпропионамида) | |
| SU1015823A3 (ru) | Способ получени таутомеров @ -5-амино-4,5,6,7-тетрагидро-1н-индазола и @ -5-амино-4,5,6,7-тетрагидро-2н-индазола | |
| SU1133272A1 (ru) | Ди- @ -оксисукцинимидный эфир щавелевой кислоты в качестве реагента дл синтеза @ -оксисукцинимидных эфиров @ -защищенных аминокислот | |
| RU2368603C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ 5-(n-ЭТИЛКАРБОКСИФЕНИЛ)-, 5-(n-β-ДИЭТИЛАМИНОЭТИЛКАРБОКСИФЕНИЛ)- И 5-(n-СУЛЬФАЦЕТАМИДФЕНИЛ)-1,3,5-ДИТИАЗИНАНОВ | |
| JPH0571593B2 (cg-RX-API-DMAC10.html) | ||
| HK1215809B (en) | Method for producing tricyclic compound, and tricyclic compound capable of being produced by said production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PFA | Name/firm changed |
Owner name: FARMITALIA CARLO ERBA S.R.L. |
|
| PL | Patent ceased | ||
| PL | Patent ceased |